Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).

The global Alpha Blockers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Alpha Blockers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alpha Blockers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Alpha Blockers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Alpha Blockers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Non-selective Antagonists
Selective Antagonists

Segment by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction